Pelayo Cortina Koplowitz cierra un acuerdo con Goldman de 145 millones para desarrollar su resort en Marbella

Pelayo Cortina Koplowitz, CEO of Oakmond, has signed a €145 million senior financing agreement with Goldman Sachs Alternatives to develop their luxury and longevity resort in Marbella. This development marks the transformation of the iconic Incosol hotel and is supported by an asset base and capital of over €400 million. The development budget is estimated at €260 million, with €145 million provided by Goldman Sachs Alternatives through a loan and Ilanga Capital contributing the remaining funds as equity.

This financial solidity will aid in completing the construction and consolidating the brand, while also allowing for the launch of new research in longevity. Pelayo Cortina Koplowitz stated that this strategic support confirms Oakmond's vision to become the world leader in this sector. Rossitsa Koevska from Real Estate at Goldman Sachs Alternatives expressed their enthusiasm to support Ilanga Capital and their experienced development team in delivering an iconic asset in the luxury hospitality landscape, appealing to a global audience seeking a leader in longevity and wellness.

The new luxury and longevity complex will be built on the former Incosol hotel site in Marbella, estimated to cost over 53,000 square meters and include 140 luxury rooms, 28 private residences, extensive fitness areas, and a carefully crafted gastronomic proposal. Oakmond aims to create a new category in the market where medicine is the main product and hospitality creates the environment for deeper diagnostics, longer adherence to treatment, prolonged commitment, and better results.

The project will establish a precision health ecosystem that integrates luxury hospitality, comprehensive medical diagnostics, personalized interventions, continuous health monitoring, and data-driven clinical intelligence to monitor patients' health over time.